HomeQuestion

How do you decide on a salvage regimen for relapsed/refractory DLBCL, assuming a patient is transplant eligible?

1

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

How would you treat a stage I fully resected double hit DLBCL?

Does the recent publication of EPCORE FL-1 (Epcoritamab + R2) change your preferred 2L SOC for R/R FL?

How have the results of the SUNMO trial with mosunetuzumab/polatuzumab vedotin impacted your treatment choices for transplant ineligible relapsed/refractory DLBCL?

Would you use routine PET scans after two cycles of R-CHOP to guide first-line treatment de-escalation in low-risk (aaIPI = 0) DLBCL patients?

In light of frontMIND data, are you anticipating a change in your treatment preference for patients with newly diagnosed high-risk DLBCL?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.